blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2043636

EP2043636 - (COMBI) COMPOSITIONS FOR THE TREATMENT OF MUCORMYCOSIS COMPRISING IRON CHELATOR AND ANTIFUNGAL AGENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.01.2015
Database last updated on 13.11.2024
Most recent event   Tooltip23.01.2015Application deemed to be withdrawnpublished on 25.02.2015  [2015/09]
Applicant(s)For all designated states
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
1124 West Carson Street
Torrance, CA 90502 / US
[2009/15]
Inventor(s)01 / IBRAHIM, Ashraf, S.
8192 Andora Drive
La Mirada, CA 90638 / US
02 / SPELLBERG, Brad, J.
30140 Avenida Celestial
Rancho Palos Verdes, CA 90275 / US
03 / EDWARDS, John, E.
3708 Via La Selva
Palos Verdes, CA 90274 / US
 [2009/15]
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[N/P]
Former [2010/26]Müller-Boré & Partner Patentanwälte
Grafinger Strasse 2
81671 München / DE
Former [2009/15]Hill, Justin John, et al
McDermott Will & Emery UK LLP 7 Bishopsgate
London EC2N 3AR / GB
Application number, filing date07796874.113.07.2007
[2009/15]
WO2007US16065
Priority number, dateUS20060831099P13.07.2006         Original published format: US 831099 P
US20070897620P26.01.2007         Original published format: US 897620 P
US20070904075P27.02.2007         Original published format: US 904075 P
[2009/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008008537
Date:17.01.2008
Language:EN
[2008/03]
Type: A2 Application without search report 
No.:EP2043636
Date:08.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 17.01.2008 takes the place of the publication of the European patent application.
[2009/15]
Search report(s)International search report - published on:EP24.04.2008
ClassificationIPC:A61K31/4196, A61K31/4412, A61K31/7048, A61P31/10
[2009/15]
CPC:
A61K31/4196 (EP,KR,US); A61K31/4412 (EP,KR,US); A61K31/7048 (EP,KR,US);
A61K45/06 (EP,US); A61P31/10 (EP); A61P43/00 (EP);
Y02A50/30 (EP,US) (-)
C-Set:
A61K31/4196, A61K2300/00 (EP,US);
A61K31/4412, A61K2300/00 (US,EP);
A61K31/7048, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/15]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:(KOMBI)-ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON MUCORMYCOSIS MIT EISENCHELATBILDNER UND ANTIMYKOTISCHEM MITTEL[2009/15]
English:(COMBI) COMPOSITIONS FOR THE TREATMENT OF MUCORMYCOSIS COMPRISING IRON CHELATOR AND ANTIFUNGAL AGENT[2009/15]
French:COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DE LA MUCORMYCOSE ET D'AUTRES MALADIES FONGIQUES[2009/15]
Entry into regional phase12.02.2009National basic fee paid 
12.02.2009Designation fee(s) paid 
12.02.2009Examination fee paid 
Examination procedure12.02.2009Examination requested  [2009/15]
03.04.2009Amendment by applicant (claims and/or description)
12.05.2009Despatch of a communication from the examining division (Time limit: M06)
16.11.2009Reply to a communication from the examining division
21.07.2011Despatch of a communication from the examining division (Time limit: M06)
20.12.2011Reply to a communication from the examining division
10.03.2014Despatch of a communication from the examining division (Time limit: M06)
23.09.2014Application deemed to be withdrawn, date of legal effect  [2015/09]
16.10.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/09]
Divisional application(s)EP11003922.9  / EP2412371
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.05.2009
Fees paidRenewal fee
28.07.2009Renewal fee patent year 03
26.07.2010Renewal fee patent year 04
28.07.2011Renewal fee patent year 05
13.07.2012Renewal fee patent year 06
10.07.2013Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.07.201408   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2004045609  (GHISALBERTI CARLO [BR]) [X] 1-13,26-44 * claim 1 * * page 9 * * page 1, lines 4-6 * * page 9, line 13 - line 17 * * page 9, line 25 *;
 [Y]WO2004060903  (NEKTAR THERAPEUTICS [US], et al) [Y] 1-13,26-44 * abstract *;
 [Y]WO2004108114  (PATEL DINESH SHANTILAL [IN], et al) [Y] 1-13,26-44 * abstract *;
 [X]WO2005051411  (BIOFRONTERA DISCOVERY GMBH [DE], et al) [X] 1-44 * page 1, paragraph 1 * * page 2, paragraph 1 * * page 1, paragraph L *;
 [X]  - MENCACCI ANTONELLA ET AL, "Iron overload alters innate and T helper cell responses to Candida albicans in mice", JOURNAL OF INFECTIOUS DISEASES, (1997), vol. 175, no. 6, ISSN 0022-1899, pages 1467 - 1476, XP009091625 [X] 1-44 * abstract * * page 1474, column L, paragraph 1 * * page 1475, column L, paragraph L *
 [Y]  - KATTAMIS ET AL, "Iron chelation treatment with combined therapy with deferiprone and deferioxamine: A 12-month trial", BLOOD CELLS, MOLECULES AND DISEASES, LAJOLLA, US, (200601), vol. 36, no. 1, ISSN 1079-9796, pages 21 - 25, XP005235037 [Y] 1-44 * abstract *

DOI:   http://dx.doi.org/10.1016/j.bcmd.2005.11.002
 [Y]  - WEISS H MARKUS ET AL, "In vitro blood distribution and plasma protein binding of the iron chelator deferasirox (ICL670) and its iron complex Fe-[ICL670](2) for rat, marmoset, rabbit, mouse, dog, and human", DRUG METABOLISM AND DISPOSITION, (200606), vol. 34, no. 6, ISSN 0090-9556, pages 971 - 975, XP002465309 [Y] 1-44 * abstract *
Examination   - JOHAN R BOELAERT ET AL, "Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect", KIDNEY INTERNATIONAL, LONDON, GB, (19940301), vol. 45, no. 3, doi:10.1038/ki.1994.89, ISSN 0085-2538, pages 667 - 671, XP055105095

DOI:   http://dx.doi.org/10.1038/ki.1994.89
    - B. SPELLBERG ET AL, "Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management", CLINICAL MICROBIOLOGY REVIEWS, (20050701), vol. 18, no. 3, doi:10.1128/CMR.18.3.556-569.2005, ISSN 0893-8512, pages 556 - 569, XP055105082

DOI:   http://dx.doi.org/10.1128/CMR.18.3.556-569.2005
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.